HMGB1 and neoplasm: The release of IL-1β, which may contribute to T-cell priming by dendritic cells in tumor microenvironment (7), has been associated with the production of other immunomodulatory molecules, such as HMGB1 and ATP, from radiation-exposed tumor cells that favor antigen processing and cross-presentation by dendritic cells (7).